This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...

Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...

Los Angeles, Calif. – Testosterone therapy does not cause adverse effects on the prostate in older men with hypogonadism, commonly known as low testosterone or low T, according to a clinical trial ...

In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...

The testosterone threshold should be less than 10 ng/dL rather than less than 50 ng/dL for gauging advanced prostate cancer prognosis in patients on ADT. Examining sustained testosterone suppression ...

Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of testosterone therapy: cancer! I survived advanced prostate cancer seven years ...

Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its classification as a controlled substance. Like previous FDA expert panels, the ...

A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...

Testosterone therapy, broadly referred to as Testosterone Replacement Therapy (TRT), increased approximately 27% from 2008 to 2022 with up to approximately 3% of all US adults having a prescription.